TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04113967

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Biodanza program
Description: Biodanza is a form of intervention aimed at promoting health and well-being through the promotion of self-expression and self-regulation through interaction through music and dance. The music accompanied by the movement of the body induces some experiences that present the ability to modify the organism itself both at an organic level, as affective-motor and existential. This intervention constitutes a means for the correct development of human qualities, whose purpose is to integrate the potentials of bond, health and harmony, as well as to develop new alternatives for the life of each individual.
Study: NCT03863314

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual Simulation
Description: Virtual simulation of workplace-related scenarios of pre-recorded videos using the same actors

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: In-person Simulation
Description: In-person simulation of workplace-related scenarios with live actors
Study: NCT03871686

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief Internet-based Behavioral Activation Intervention
Description: A brief Internet-based behavioral activation intervention consisting of 4 sessions.
Study: NCT03043144

Intervention type: OTHER
Intervention: Worsening of olfaction from enrollment visit to 6 months
Description: Worsening of olfaction from enrollment visit to 6 months will be evaluated for association with the primary and secondary outcomes
Study: NCT02911805

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Aerobic exercise
Description: Stationary bicycle ergometer @ 50-80% of maximal heart rate reserve for 20 minutes to 45 minutes

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Balance exercise
Description: Instructor-led exercises done in a group setting for strengthening, balance, flexibility
Study: NCT02664805

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: LEO 124249 ointment
Description: Ointment

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: LEO 124249 ointment vehicle
Description: Ointment vehicle
Study: NCT01351220

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Educational program and FOBT kits
Description: Subjects will participate in a CRC small group educational program and receive FOBT kits from community health advisors who have received a one-time training session.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Educational program and FOBT kits, and technical assistance
Description: In addition to subjects' receipt of a CRC small group educational program and FOBT kits, leadership training and technical support will be provided to the community health advisors and selected leaders and members of the organization.
Study: NCT05172622

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JP-2266
Description: * Single Ascending Dose: Single administration on Day 1~* Food effect cohort: Single administration on Day 1 of each period~* Multiple Ascending Dose: Repeated administrations from D1 to D15

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: JP-2266 Placebo
Description: * Single Ascending Dose: Single administration on Day 1~* Food effect cohort: Single administration on Day 1 of each period~* Multiple Ascending Dose: Repeated administrations from D1 to D15
Study: NCT01924091

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapivirine gel

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapivirine film
Study: NCT01860729

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study: NCT01606917

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle counseling
Description: Both dietary advice and individualized advice on increased regular physical activity
Study: NCT04048278

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lidocaine Hydrochloride
Description: IV Lidocaine a 1.0 - 1.5 mg/kg loading infusion for perioperative pain control

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline Solution for Injection
Description: IV Saline a 1.0 - 1.5 mg/kg loading infusion for perioperative pain control
Study: NCT00946140

Intervention type: PROCEDURE
Intervention: DCE-MRI scans
Description: Initially you will be given safety information about MRI scans and a questionnaire to determine your compatibility with the MRI scanner. For each patient, DCE-MRI data sets will be acquired three times - at baseline just prior to the start of the drug therapy, within 24-48 hours of the start of the therapy, and within 6-8 weeks of the start of the therapy.
Study: NCT03002467

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PESI score
Study: NCT00028145

Intervention type: BEHAVIORAL
Intervention: Adherence assessment
Description: Adherence will be assessed using questionnaires at all study visits.
Study: NCT01608022

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF804
Description: 45 mg p.o. daily and continuously (28-day treatment as one treatment cycle)
Study: NCT03278119

Intervention type: DIAGNOSTIC_TEST
Intervention: PET Scan and nocturnal polysomnography
Description: Amyloid PET scans will be used to assess amyloid burden in the brain, and nocturnal polysomnography will be used to assess sleep and cardiopulmonary variables

Intervention type: DIAGNOSTIC_TEST
Intervention: PET Scan and nocturnal polysomnography
Description: Amyloid PET scans will be used to assess amyloid burden in the brain, and nocturnal polysomnography will be used to assess sleep and cardiopulmonary variables
Study: NCT02322853

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tamoxifen
Description: hormonotherapy

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tamoxifen
Description: hormonotherapy

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ralimetinib (LY2228820 dimesylate)
Study: NCT03043144

Intervention type: OTHER
Intervention: Worsening of taste from enrollment visit to 6 months
Description: Worsening of taste from enrollment visit to 6 months will be evaluated for association with the primary and secondary outcomes
Study: NCT01291485

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Life Steps for Medication Adherence
Description: The intervention was adapted into an electronic version of the empirically supported Life Steps intervention for HIV medication adherence. Education about HIV and medication adherence, motivational interviewing, cognitive behavioral techniques, and problem-solving strategies to improve medication adherence and clinical outcomes in people living with HIV were also included in the intervention.
Study: NCT04769180

Intervention type: OTHER
Intervention: Evaluation of extraintestinal manifestations
Description: The researchers evaluated the prevalence and kind of extraintestinal symptoms in NCWS patients and the possible relationship between the clinical, serological, genetic and histological characteristics of the NCWS patients and the number and kind of extraintestinal manifestations, using, as control groups, CD and IBS patients.

Intervention type: OTHER
Intervention: Evaluation of extraintestinal manifestations
Description: The researchers evaluated the prevalence and kind of extraintestinal symptoms in NCWS patients and the possible relationship between the clinical, serological, genetic and histological characteristics of the NCWS patients and the number and kind of extraintestinal manifestations, using, as control groups, CD and IBS patients.

Intervention type: OTHER
Intervention: Evaluation of extraintestinal manifestations
Description: The researchers evaluated the prevalence and kind of extraintestinal symptoms in NCWS patients and the possible relationship between the clinical, serological, genetic and histological characteristics of the NCWS patients and the number and kind of extraintestinal manifestations, using, as control groups, CD and IBS patients.
Study: NCT03756493

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Periodontal Surgery with OFD+ABG+L-PRF
Description: Patients will be treated by periodontal surgical flaps with the addition of L-PRF+ Autogenous Bone Graft filling material.
Study: NCT03043144

Intervention type: OTHER
Intervention: Serum Zinc
Description: Serum zinc will be evaluated for association with taste and/or smell impairment

Intervention type: OTHER
Intervention: Chronic rhinosinusitis
Description: Chronic rhinosinusitis will be evaluated for association with smell impairment

Intervention type: OTHER
Intervention: Dialysis adequacy
Description: Dialysis adequacy will be evaluated for association with taste and/or smell impairment

Intervention type: OTHER
Intervention: Decayed missing filled teeth index (DMFT)
Description: DMFT will be evaluated for association with taste impairment
Study: NCT03002597

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BrainPort V200 Device
Description: To see if the device can be used in a pediatric population by measuring the subjects' improvement over baseline in any of the following areas: light detection, light localization, movement perception, and standardized object recognition tasks after use of the BrainPort.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BrainPort V200 Device
Description: To see if the device can be used in a pediatric population by measuring the subjects' improvement over baseline in any of the following areas: light detection, light localization, movement perception, and standardized object recognition tasks after use of the BrainPort.
Study: NCT01646359

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 1.Esophageal doppler monitor
Description: 1.Esophageal doppler monitor (CARDIO Q®, DELTEX MEDICAL. Brighton, U. K.)-inserted into the esophagus and positioned approximately 35-40 cm from the teeth. The position of OED prove was confirmed by continuously measuring blood flow velocity in the descending thoracic aorta and focused to find the optimum peak velocity and waveform signal.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 2. philips Intelivue MP70 monitors
Description: 2.philips Intelivue MP70 monitors (Intellivue MP70, philips medical Systems, Suresnes, France) -a radial arterial cannula was inserted and arterial pressure waveforms were monitored through Philips Intelivue MP70 monitors. In the monitor, PPVauto was displayed in real-time. It based on automatic detection algorithms, kernel smoothing, and rank-order filters.
Study: NCT02532348

Intervention type: OTHER
Intervention: Blood samples
Description: Blood samples

Intervention type: OTHER
Intervention: Blood samples
Description: Blood samples
Study: NCT02870725

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CBT Individual Psychotherapy
Description: The 4-session CBT treatment will include receipt of a manualized cognitive behavioral intervention, delivered individually, to treat the depression symptoms (e.g. cognitive restructuring, behavioral activation) and teach adaptive coping strategies to manage their depression. Ideally, the intervention will also positively affect their chronic headaches (i.e. reduction of headache frequency, severity and level of disability). Each session is approximately 60 minutes with specific, reflective and guided activities related to a specific module within the intervention.
Study: NCT02764541

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Letrozole

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Letrozole

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tamoxifen

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tamoxifen

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Palbociclib

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Palbociclib

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Endocrine Therapy

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Endocrine Therapy

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Endocrine Therapy

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Endocrine Therapy
Study: NCT00360997

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Conventional UK physical therapy
Study: NCT01990261

Intervention type: DRUG
Intervention: Erlotinib
Description: Erlotinib at a dose determined by the investigator, guided by the recommendation in the Summary of Product Characteristics.
Study: NCT02853760

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: walking

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: walking

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Treadmill
Study: NCT04452890

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Sonourethrography
Description: Ultrasound of the urethra.
Study: NCT00360997

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Con UK PT + Mobilisation & tactile stimulation (MTS)
Description: Con UK PT + Mobilisation \& Tactile Stimulation (MTS) which is further randomised to 30, 60 or 120 mins/day
Study: NCT04355104

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Education
Description: A one hour educational session per week for 4 weeks. In a total of 4 sessions of education, the content based on LBP Clinical Practice Guidelines which recommended that education and counseling strategies for patients with low back pain.~Education session will be through video lecturing as a motivated tool of education for all subject who are in experimental group, this video will repeated the same in every educational session and will be sent for all participants.~The neuroscience education will be by the therapist using interactive slide show and hand-drawing images.~In addition to the education video, slide show, we will specify the education for every patient to give him all that he need, questions and details, mention his case on real spine to explore it and to determine the expected goal from what he need and what we have.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standard physical therapy
Description: Two session physical therapy per week for 4 weeks. The physical therapy will be based on patients case.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard physical therapy
Description: Two session physical therapy per week for 4 weeks. The physical therapy will be based on patients case.
Study: NCT03756493

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Periodontal Surgery with OFD+ABG
Description: Patients will be treated by periodontal surgical flaps with the addition of Autogenous Bone Graft filling material.
Study: NCT01972204

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intensive adherence instruction
Description: Instruction with educational brochure

Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Control
Description: Instruction as per usual practice
Study: NCT03962348

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Specialized Early Engagement Support Service
Description: The Specialized Early Engagement Support Service (SEESS - a Social Worker and Peer Specialist) will link detainees with first-episode psychosis (FEP), using tenets of person-centered treatment and shared decision-making, and the Critical Time Intervention model, to community-based Coordinated Specialty Care (CSC).
Study: NCT03109132

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Oridion Smart CapnoLine® H Plus with Wedge cannula
Description: The subjects will assess the comfort level of the different cannulas

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Oridion Smart CapnoLine® Plus with Non-Wedge cannula
Description: The subjects will assess the comfort level of the different cannulas

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Experimental sample line Model 3
Description: The subjects will assess the comfort level of the different cannulas

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Experimental sample line Model 4
Description: The subjects will assess the comfort level of the different cannulas

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Experimental sample line Model 5
Description: The subjects will assess the comfort level of the different cannulas

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: O2/CO2 cannula w/female luer (Westmed comfort plus #0504)
Description: The subjects will assess the comfort level of the different cannulas
Study: NCT00546897

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenalidomide

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenalidomide
Study: NCT00715377

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Benztropine
Description: Patients aged ≥ 50 years suffering from a primary psychotic disorder treated with a SGA and benztropine concomittantly at any dose steadily for at least 3 months will be eligible to participate in this study. The dose of benztropine will be reduced by 0.5mg per week. During this 8-week study period, extrapyramidal symptoms will be assessed on a weekly basis. The clinical assessments will be repeated 8 weeks after the initial assessments.
Study: NCT04236960

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Meningococcal Group ACYW135 Conjugate Vaccine
Description: 1 dose in Stage 1 (2\~55 yrs), 2 doses in Stage 2 (7\~23 mos), and 3 doses in Stage 3 (2\&3 mos)

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Meningococcal Group ACYW135 Conjugate Vaccine
Description: 1 dose in Stage 1 (2\~55 yrs), 2 doses in Stage 2 (7\~23 mos), and 3 doses in Stage 3 (2\&3 mos)
Study: NCT03756493

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Periodontal Surgery OFD
Description: Patients will be treated by Open Flap Debridement without use of filling material.
Study: NCT02087267

Intervention type: PROCEDURE
Intervention: 1- or 2-level spinal fusion
Description: 1- or 2-level lumbar or lumbar-sacral spinal fusion with the icotec CF/PEEK Pedicle System in combination with the icotec CF/PEEK TLIF Cage ETurn™
Study: NCT02925416

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oritavancin
Description: Administered intravenously

Intervention type: DRUG
Group type: OTHER
Intervention: Oritavancin
Description: Administered intravenously

Intervention type: DRUG
Group type: OTHER
Intervention: Placebo (D5W)
Description: Administered intravenously
Study: NCT04925856

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: blood sample
Description: •Blood sample:~* 1 heparinized tube (4 mL) for collection of plasma and storage~* 1 heparinized tube (4 mL) for immunophenotyping,~* 4 EDTA tubes (4 x 10 mL) for collecting white blood cells (PBMC) for cryopreservation.
Study: NCT05239429

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Transcendental Meditation Technique
Description: Participants receive one-on-one training on how to use Transcendental Meditation technique which is then practiced twice daily for approximately 20 minutes.
Study: NCT05464953

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Triamcinolone Acetonide
Description: Triamcinolone Acetonide is a corticosteroid that has antiangiogenic and anti-inflammatory effects that can inhibit the expression of VEGF and other proinflammatory cytokines, improving best-corrected visual acuity and decreasing central retinal thickness (CRT) in patients with macular edema

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Triamcinolone Acetonide
Description: Triamcinolone Acetonide is a corticosteroid that has antiangiogenic and anti-inflammatory effects that can inhibit the expression of VEGF and other proinflammatory cytokines, improving best-corrected visual acuity and decreasing central retinal thickness (CRT) in patients with macular edema

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Formulated Triamcinolone
Description: Formulated Triamcinolone: is triamcinolone and sodium hyaluronate and chondroitin sulfate
Study: NCT01517360

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxytocin
Description: Oxytocin 40 IU, intranasal inhalation

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Placebo, matched to Oxytocin, intranasal inhalation

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Social Cognitive Skills Training
Description: The training utilizes skill building techniques that are commonly used in psychiatric rehabilitation. These include breaking down complex social cognitive processes into their components and automating these skills through repetition and practice. The training programs will include 12 sessions and will be administered in a small group format (6-8 participants per group) twice a week for 6 weeks. Each training session will last for about 90 minutes (1 hour training and 30 minutes between drug administration and start of training).

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Social Cognitive Skills Training
Description: The training utilizes skill building techniques that are commonly used in psychiatric rehabilitation. These include breaking down complex social cognitive processes into their components and automating these skills through repetition and practice. The training programs will include 12 sessions and will be administered in a small group format (6-8 participants per group) twice a week for 6 weeks. Each training session will last for about 90 minutes (1 hour training and 30 minutes between drug administration and start of training).
Study: NCT00613912

Intervention type: OTHER
Intervention: Magnetic Resonance Imaging
Description: * Morphological sequences~* Arterial Spin Labelling (Perfusion)~* Spectroscopy: anterior cingulate cortex Naa, Cho, Cr, Myo-inositol, glutamate TE 30 Reference voxel in Parietal white matter
Study: NCT01022008

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Osteodistraction techniques
Description: Treatment based on craniofacial osteotomies and osteodistraction techniques.
Study: NCT04618510

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SEED 1-dayPure EDOF soft contact lens
Description: Centre-distance contact lens with peripheral add power working on extended depth of focus principle to control myopia

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Single Vision Spectacles
Description: These are the type of glasses that correct vision for a single distance
Study: NCT03380156

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TVS
Description: Active TVS will be performed by use of a Tragus stimulator device with electrodes attached to the tragus of the ear. Stimulator will be applied continuously for 1 hour

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Sham TVS
Description: Device will be applied but not to the Tragus of the ear but will be attached to the ear lobule.
Study: NCT02862509

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Budesonide nasal instillation